# CommBio Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/commbio-therapeutics

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Angel (Nov 23, 2019)
- Investors on record: 1

## About

Based in Suzhou, China and established in 2019, CommBio Therapeutics operates as biopharmaceutical developer that focues on bacterial vector gene therapy.

The company provides bacterial vector gene therapy and related products for patients such as phenylketonuria (PKU). The product of the company includes synb1618 and synb1934.

The company will increase investment in researching and developing product and promote clinical projects.

## Funding rounds

- Angel, Nov 23, 2019 — MED-FINE Capital

## Investors

- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Angel